BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21666174)

  • 1. Strategic planning for measles control: using data to inform optimal vaccination strategies.
    Simons E; Mort M; Dabbagh A; Strebel P; Wolfson L
    J Infect Dis; 2011 Jul; 204 Suppl 1():S28-34. PubMed ID: 21666174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global eradication of measles: an epidemiologic and economic evaluation.
    Levin A; Burgess C; Garrison LP; Bauch C; Babigumira J; Simons E; Dabbagh A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S98-106. PubMed ID: 21666220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How can measles eradication strengthen health care systems?
    Griffiths UK; Mounier-Jack S; Oliveira-Cruz V; Balabanova D; Hanvoravongchai P; Ongolo P
    J Infect Dis; 2011 Jul; 204 Suppl 1():S78-81. PubMed ID: 21666217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using cost-effectiveness analysis to support research and development portfolio prioritization for product innovations in measles vaccination.
    Garrison LP; Bauch CT; Bresnahan BW; Hazlet TK; Kadiyala S; Veenstra DL
    J Infect Dis; 2011 Jul; 204 Suppl 1():S124-32. PubMed ID: 21666153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience in global measles control, 1990-2001.
    Henao-Restrepo AM; Strebel P; John Hoekstra E; Birmingham M; Bilous J
    J Infect Dis; 2003 May; 187 Suppl 1():S15-21. PubMed ID: 12721887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of immunization programs in Colombia.
    Creese AL; Domínguez-Uga MA
    Bull Pan Am Health Organ; 1987; 21(4):377-94. PubMed ID: 3125875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Strategies of measles eradication in the world].
    Olivé JM
    Rev Esp Salud Publica; 1999; 73(5):597-603. PubMed ID: 10650750
    [No Abstract]   [Full Text] [Related]  

  • 8. Measles: not just another viral exanthem.
    Duke T; Mgone CS
    Lancet; 2003 Mar; 361(9359):763-73. PubMed ID: 12620751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preplanned national measles vaccination campaign at the beginning of a measles outbreak--Sierra Leone, 2009-2010.
    Sugerman DE; Fall A; Guigui MT; N'dolie M; Balogun T; Wurie A; Goodson JL
    J Infect Dis; 2011 Jul; 204 Suppl 1():S260-9. PubMed ID: 21666171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there enough vaccine to eradicate measles? An integrated analysis of measles-containing vaccine supply and demand.
    Smith G; Michelson J; Singh R; Dabbagh A; Hoekstra E; van den Ent M; Mallya A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S62-70. PubMed ID: 21666215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of vaccination policies. The case of measles].
    Lafarge H; Levy E; Rey M
    Rev Epidemiol Sante Publique; 1985; 33(3):182-93. PubMed ID: 4081224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The unfinished measles immunization agenda.
    Strebel P; Cochi S; Grabowsky M; Bilous J; Hersh BS; Okwo-Bele JM; Hoekstra E; Wright P; Katz S
    J Infect Dis; 2003 May; 187 Suppl 1():S1-7. PubMed ID: 12721885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress toward measles elimination--Southern Africa, 1996-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jul; 48(27):585-9. PubMed ID: 10428097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current impact of measles in Latin America.
    Borgoño JM
    Rev Infect Dis; 1983; 5(3):417-21. PubMed ID: 6878992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Costs and benefits of measles vaccination].
    Ambrosch F; Wiedermann G; Harasek G
    Fortschr Med; 1978 Feb; 96(8):409-14. PubMed ID: 415953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress toward global measles control and regional elimination, 1990-1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Dec; 47(48):1049-54. PubMed ID: 9869078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ambitious measles vaccination program in Vietnam].
    Björklund J; Strand M; Blennow M
    Lakartidningen; 2006 Apr 26-May 2; 103(17):1325-7. PubMed ID: 16708862
    [No Abstract]   [Full Text] [Related]  

  • 18. What will it take to achieve measles elimination in the World Health Organization European Region: progress from 2003-2009 and essential accelerated actions.
    Martin R; Wassilak S; Emiroglu N; Uzicanin A; Deshesvoi S; Jankovic D; Goel A; Khetsuriani N
    J Infect Dis; 2011 Jul; 204 Suppl 1(Suppl 1):S325-34. PubMed ID: 21666181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Measles in the Local Health Unit Naples 4: vaccination coverage, epidemic 2001-2002 and prevention strategies].
    Gigli L; Graziano M; Manetta G; Palombino R
    Ann Ig; 2004; 16(5):627-32. PubMed ID: 15552728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determining measles-containing vaccine demand and supply: an imperative to support measles mortality reduction efforts.
    Costa A; Henao-Restrepo AM; Marie Hall S; Jarrett S; Hoekstra EJ
    J Infect Dis; 2003 May; 187 Suppl 1():S22-8. PubMed ID: 12721888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.